Table of Content

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Lateral Flow Assay Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Product (Kits & Reagents, Lateral Flow Readers, Others)
5.2.2. By Application (Clinical Testing, Cardiac Marker Testing, Pregnancy & Fertility Testing, Veterinary Diagnostics, Others)
5.2.2.1. By Clinical Testing (Infectious Disease Testing, Hepatitis, Tuberculosis, Others)
5.2.2.2. By Cardiac Marker Testing (Troponin I and T Testing, CK-MB Testing, Myoglobin Testing, D-Dimer Testing, Others)
5.2.2.3. By Pregnancy & Fertility Testing (Pregnant Testing v/s Fertility Testing)
5.2.3. By Technique (Sandwich Assay, Competitive Assay, Multiplex Detection Assay)
5.2.4. By Test Type (Lateral Flow Immunoassay v/s Nucleic Acid Lateral Flow Assay)
5.2.5. By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)
5.2.6. By Region
5.2.7. By Company (2022)
5.3. Market Map
5.3.1. By Product
5.3.2. By Application
5.3.3. By Technique
5.3.4. By Test Type
5.3.5. By End User
5.3.6. By Region
6. North America Lateral Flow Assay Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product (Kits & Reagents, Lateral Flow Readers, Others)
6.2.2. By Application (Clinical Testing, Cardiac Marker Testing, Pregnancy & Fertility Testing, Veterinary Diagnostics, Others)
6.2.2.1. By Clinical Testing (Infectious Disease Testing, Hepatitis, Tuberculosis, Others)
6.2.2.2. By Cardiac Marker Testing (Troponin I and T Testing, CK-MB Testing, Myoglobin Testing, D-Dimer Testing, Others)
6.2.2.3. By Pregnancy & Fertility Testing (Pregnant Testing v/s Fertility Testing)
6.2.3. By Technique (Sandwich Assay, Competitive Assay, Multiplex Detection Assay)
6.2.4. By Test Type (Lateral Flow Immunoassay v/s Nucleic Acid Lateral Flow Assay)
6.2.5. By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)
6.2.6. By Country
6.3. North America: Country Analysis
6.3.1. United States Lateral Flow Assay Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Product
6.3.1.2.2. By Application
6.3.1.2.3. By Technique
6.3.1.2.4. By Test Type
6.3.1.2.5. By End User
6.3.2. Mexico Lateral Flow Assay Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Product
6.3.2.2.2. By Application
6.3.2.2.3. By Technique
6.3.2.2.4. By Test Type
6.3.2.2.5. By End User
6.3.3. Canada Lateral Flow Assay Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Product
6.3.3.2.2. By Application
6.3.3.2.3. By Technique
6.3.3.2.4. By Test Type
6.3.3.2.5. By End User
7. Europe Lateral Flow Assay Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Product (Kits & Reagents, Lateral Flow Readers, Others)
7.2.2. By Application (Clinical Testing, Cardiac Marker Testing, Pregnancy & Fertility Testing, Veterinary Diagnostics, Others)
7.2.2.1. By Clinical Testing (Infectious Disease Testing, Hepatitis, Tuberculosis, Others)
7.2.2.2. By Cardiac Marker Testing (Troponin I and T Testing, CK-MB Testing, Myoglobin Testing, D-Dimer Testing, Others)
7.2.2.3. By Pregnancy & Fertility Testing (Pregnant Testing v/s Fertility Testing)
7.2.3. By Technique (Sandwich Assay, Competitive Assay, Multiplex Detection Assay)
7.2.4. By Test Type (Lateral Flow Immunoassay v/s Nucleic Acid Lateral Flow Assay)
7.2.5. By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)
7.2.6. By Country
7.3. Europe: Country Analysis
7.3.1. France Lateral Flow Assay Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Product
7.3.1.2.2. By Application
7.3.1.2.3. By Technique
7.3.1.2.4. By Test Type
7.3.1.2.5. By End User
7.3.2. Germany Lateral Flow Assay Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Product
7.3.2.2.2. By Application
7.3.2.2.3. By Technique
7.3.2.2.4. By Test Type
7.3.2.2.5. By End User
7.3.3. United Kingdom Lateral Flow Assay Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Product
7.3.3.2.2. By Application
7.3.3.2.3. By Technique
7.3.3.2.4. By Test Type
7.3.3.2.5. By End User
7.3.4. Italy Lateral Flow Assay Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Product
7.3.4.2.2. By Application
7.3.4.2.3. By Technique
7.3.4.2.4. By Test Type
7.3.4.2.5. By End User
7.3.5. Spain Lateral Flow Assay Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Product
7.3.5.2.2. By Application
7.3.5.2.3. By Technique
7.3.5.2.4. By Test Type
7.3.5.2.5. By End User
8. Asia-Pacific Lateral Flow Assay Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Product (Kits & Reagents, Lateral Flow Readers, Others)
8.2.2. By Application (Clinical Testing, Cardiac Marker Testing, Pregnancy & Fertility Testing, Veterinary Diagnostics, Others)
8.2.2.1. By Clinical Testing (Infectious Disease Testing, Hepatitis, Tuberculosis, Others)
8.2.2.2. By Cardiac Marker Testing (Troponin I and T Testing, CK-MB Testing, Myoglobin Testing, D-Dimer Testing, Others)
8.2.2.3. By Pregnancy & Fertility Testing (Pregnant Testing v/s Fertility Testing)
8.2.3. By Technique (Sandwich Assay, Competitive Assay, Multiplex Detection Assay)
8.2.4. By Test Type (Lateral Flow Immunoassay v/s Nucleic Acid Lateral Flow Assay)
8.2.5. By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)
8.2.6. By Country
8.3. Asia-Pacific: Country Analysis
8.3.1. China Lateral Flow Assay Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Product
8.3.1.2.2. By Application
8.3.1.2.3. By Technique
8.3.1.2.4. By Test Type
8.3.1.2.5. By End User
8.3.2. India Lateral Flow Assay Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Product
8.3.2.2.2. By Application
8.3.2.2.3. By Technique
8.3.2.2.4. By Test Type
8.3.2.2.5. By End User
8.3.3. South Korea Lateral Flow Assay Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Product
8.3.3.2.2. By Application
8.3.3.2.3. By Technique
8.3.3.2.4. By Test Type
8.3.3.2.5. By End User
8.3.4. Japan Lateral Flow Assay Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Product
8.3.4.2.2. By Application
8.3.4.2.3. By Technique
8.3.4.2.4. By Test Type
8.3.4.2.5. By End User
8.3.5. Australia Lateral Flow Assay Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Product
8.3.5.2.2. By Application
8.3.5.2.3. By Technique
8.3.5.2.4. By Test Type
8.3.5.2.5. By End User
9. South America Lateral Flow Assay Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Product (Kits & Reagents, Lateral Flow Readers, Others)
9.2.2. By Application (Clinical Testing, Cardiac Marker Testing, Pregnancy & Fertility Testing, Veterinary Diagnostics, Others)
9.2.2.1. By Clinical Testing (Infectious Disease Testing, Hepatitis, Tuberculosis, Others)
9.2.2.2. By Cardiac Marker Testing (Troponin I and T Testing, CK-MB Testing, Myoglobin Testing, D-Dimer Testing, Others)
9.2.2.3. By Pregnancy & Fertility Testing (Pregnant Testing v/s Fertility Testing)
9.2.3. By Technique (Sandwich Assay, Competitive Assay, Multiplex Detection Assay)
9.2.4. By Test Type (Lateral Flow Immunoassay v/s Nucleic Acid Lateral Flow Assay)
9.2.5. By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)
9.2.6. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Lateral Flow Assay Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Product
9.3.1.2.2. By Application
9.3.1.2.3. By Technique
9.3.1.2.4. By Test Type
9.3.1.2.5. By End User
9.3.2. Argentina Lateral Flow Assay Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Product
9.3.2.2.2. By Application
9.3.2.2.3. By Technique
9.3.2.2.4. By Test Type
9.3.2.2.5. By End User
9.3.3. Colombia Lateral Flow Assay Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Product
9.3.3.2.2. By Application
9.3.3.2.3. By Technique
9.3.3.2.4. By Test Type
9.3.3.2.5. By End User
10. Middle East and Africa Lateral Flow Assay Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Product (Kits & Reagents, Lateral Flow Readers, Others)
10.2.2. By Application (Clinical Testing, Cardiac Marker Testing, Pregnancy & Fertility Testing, Veterinary Diagnostics, Others)
10.2.2.1. By Clinical Testing (Infectious Disease Testing, Hepatitis, Tuberculosis, Others)
10.2.2.2. By Cardiac Marker Testing (Troponin I and T Testing, CK-MB Testing, Myoglobin Testing, D-Dimer Testing, Others)
10.2.2.3. By Pregnancy & Fertility Testing (Pregnant Testing v/s Fertility Testing)
10.2.3. By Technique (Sandwich Assay, Competitive Assay, Multiplex Detection Assay)
10.2.4. By Test Type (Lateral Flow Immunoassay v/s Nucleic Acid Lateral Flow Assay)
10.2.5. By End User (Hospitals & Clinics, Diagnostic Laboratories, Others)
10.2.6. By Country
10.3. MEA: Country Analysis
10.3.1. South Africa Lateral Flow Assay Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Product
10.3.1.2.2. By Application
10.3.1.2.3. By Technique
10.3.1.2.4. By Test Type
10.3.1.2.5. By End User
10.3.2. Saudi Arabia Lateral Flow Assay Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Product
10.3.2.2.2. By Application
10.3.2.2.3. By Technique
10.3.2.2.4. By Test Type
10.3.2.2.5. By End User
10.3.3. UAE Lateral Flow Assay Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Product
10.3.3.2.2. By Application
10.3.3.2.3. By Technique
10.3.3.2.4. By Test Type
10.3.3.2.5. By End User
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Recent Developments
12.2. Mergers & Acquisitions
12.3. Product Launches
13. Global Lateral Flow Assay Market: SWOT Analysis
14. Porter’s Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Business Overview
15.2. Product Offerings
15.3. Recent Developments
15.4. Financials (As Reported)
15.5. Key Personnel
15.6. SWOT Analysis

15.6.1 Thermo Fisher Scientific, Inc.
15.6.2 Abbott Laboratories, Inc.
15.6.3 F. Hoffmann-La Roche AG
15.6.4 Bio-Rad Laboratories, Inc.
15.6.5 Quidel Corporation
15.6.6 Hologic, Inc.
15.6.7 bioM?rieux SA
15.6.8 PerkinElmer, Inc.
15.6.9 Danaher Corporation
15.6.10 QIAGEN N.V.
16. Strategic Recommendations